HRT Financial’s Mentari Therapeutics, Inc. Common Stock MTRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-192
Closed -$8K – 2800
2024
Q3
$8K Buy
192
+112
+140% +$5.71K ﹤0.01% 2239
2024
Q2
$4K Buy
+80
New +$4.57K ﹤0.01% 2050

Other funds holding MTRI

HRT Financial's MTRI Position: Q4 2024 in Review

HRT Financial sold out of Mentari Therapeutics, Inc. Common Stock (MTRI) in Q4 2024, closing a stake of 192 shares — an estimated $8K sold.

HRT Financial first reported a position in MTRI in Q2 2024 and held it in 2 quarters. The position peaked at $8K in Q3 2024. 2 funds tracked by Wall St. Rank hold MTRI as of Q4 2024.

  • HRT Financial reported no remaining Mentari Therapeutics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • HRT Financial sold 192 Mentari Therapeutics, Inc. Common Stock shares in Q4 2024, an estimated $8K.
  • HRT Financial first reported a position in Mentari Therapeutics, Inc. Common Stock in Q2 2024 and held it in 2 quarters.
  • HRT Financial's Mentari Therapeutics, Inc. Common Stock position peaked at $8K in Q3 2024.
  • 2 funds tracked by Wall St. Rank held Mentari Therapeutics, Inc. Common Stock as of Q4 2024.

Based on HRT Financial's 13F filing for Q4 2024, filed 14 Feb 2025.